Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Clarke

Showing results (51-60 of 124) with videos related to

Pageof 13
Sort By:
AIDS and Behavior|February 19, 2022
Perceptions and Practicalities Influencing Pre-exposure Prophylaxis Adherence Among Men Who Have Sex with Men in EnglandDora Arnold-Forster, Robert Horne, Will Nutland, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2016
Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 StudyFrank A Post, Pablo Tebas, Amanda Clarke, et al.
The International Journal on Drug Policy|April 19, 2019
Changes in chemsex and sexual behaviour over time, among a cohort of MSM in London and Brighton: Findings from the AURAH2 studyJaney Sewell, Valentina Cambiano, Andrew Speakman, et al.
BMJ Open|December 13, 2019
Prevalence and correlates of depressive symptoms among gay, bisexual and other men who have sex with men in the PROUD randomised clinical trial of HIV pre-exposure prophylaxisAda Miltz, Fiona Lampe, Sheena McCormack, et al.
Cardiovascular Therapeutics|October 22, 2013
Effects of neutral endopeptidase (neprilysin) inhibition on the response to other vasoactive peptides in small human resistance arteries: studies with thiorphan and omapatrilatJonathan R Dalzell, Alison Seed, Colin Berry, et al.
BMC Health Services Research|December 19, 2024
Evaluating the home-based intervention strategy (HIS-UK) to reduce new chlamydia infection among young men aged 16-25 years by promoting correct and consistent condom use: findings from a randomised controlled trialNicole Stone, Cynthia Graham, Stephen Bremner, et al.
BMC Geriatrics|July 28, 2014
Systematically searching for and assessing the literature for self-management of chronic pain: a lay users' perspectivePat Schofield, Blair H Smith, Denis Martin, et al.
Sexually Transmitted Infections|December 23, 2022
Self-start HIV postexposure prophylaxis (PEPSE), to reduce time to first dose and increase efficacyJulie M Fox, Ming Jie Lee, Cassandra Leach Fairhead, et al.
AIDS (London, England)|February 14, 2018
Changes in cerebral function parameters with maraviroc-intensified antiretroviral therapy in treatment naive HIV-positive individualsBorja Mora-Peris, George Bouliotis, Kulasegaram Ranjababu, et al.
AIDS (London, England)|July 27, 2016
Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapyWolfgang Stöhr, David T Dunn, Alejandro Arenas-Pinto, et al.
Pageof 13

Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
AIDS and Behavior|February 19, 2022
Perceptions and Practicalities Influencing Pre-exposure Prophylaxis Adherence Among Men Who Have Sex with Men in EnglandDora Arnold-Forster, Robert Horne, Will Nutland, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2016
Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 StudyFrank A Post, Pablo Tebas, Amanda Clarke, et al.
The International Journal on Drug Policy|April 19, 2019
Changes in chemsex and sexual behaviour over time, among a cohort of MSM in London and Brighton: Findings from the AURAH2 studyJaney Sewell, Valentina Cambiano, Andrew Speakman, et al.
BMJ Open|December 13, 2019
Prevalence and correlates of depressive symptoms among gay, bisexual and other men who have sex with men in the PROUD randomised clinical trial of HIV pre-exposure prophylaxisAda Miltz, Fiona Lampe, Sheena McCormack, et al.
Cardiovascular Therapeutics|October 22, 2013
Effects of neutral endopeptidase (neprilysin) inhibition on the response to other vasoactive peptides in small human resistance arteries: studies with thiorphan and omapatrilatJonathan R Dalzell, Alison Seed, Colin Berry, et al.
BMC Health Services Research|December 19, 2024
Evaluating the home-based intervention strategy (HIS-UK) to reduce new chlamydia infection among young men aged 16-25 years by promoting correct and consistent condom use: findings from a randomised controlled trialNicole Stone, Cynthia Graham, Stephen Bremner, et al.
BMC Geriatrics|July 28, 2014
Systematically searching for and assessing the literature for self-management of chronic pain: a lay users' perspectivePat Schofield, Blair H Smith, Denis Martin, et al.
Sexually Transmitted Infections|December 23, 2022
Self-start HIV postexposure prophylaxis (PEPSE), to reduce time to first dose and increase efficacyJulie M Fox, Ming Jie Lee, Cassandra Leach Fairhead, et al.
AIDS (London, England)|February 14, 2018
Changes in cerebral function parameters with maraviroc-intensified antiretroviral therapy in treatment naive HIV-positive individualsBorja Mora-Peris, George Bouliotis, Kulasegaram Ranjababu, et al.
AIDS (London, England)|July 27, 2016
Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapyWolfgang Stöhr, David T Dunn, Alejandro Arenas-Pinto, et al.
Pageof 13